Baixar PDF
Voltar à página
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Advances in hypertrophic cardiomyopathy: What the cardiologist needs to know
Alexandra Toste;
Rev Port Cardiol. 2022;41:499-509
Real-world dapagliflozin treatment patterns in Portuguese patients with heart failure with reduced ejection fraction
Aurora Andrade; Sara Gonçalves; Ana Batista; Ana Teresa Timóteo; Ana Oliveira Soares; Fátima Franco; Otília Simões; Marisa Pardal; Mário Almeida; Margarida Lopes; Filipa Bernardo; José Silva Cardoso;
10.1016/j.repc.2025.08.007
Dapagliflozin alleviates isoprenaline-induced cardiac hypertrophy by promoting mitophagy via AMPK¿2 signaling pathway
Yue Feng; Zixiong Zhu; Xin Jing; Yibo Zhang; Yubin He; Xuewen Li;
Rev Port Cardiol. 2025;44:673-87